Significantly Strengthened Balance Sheet through Recent Capital Raises and Debt Reduction
Launched COVID-19 Testing at JFK International Airport on June 22nd
Files SEC Form 10-Q for the First Quarter ending March 31, 2020 […]
Whitehorse, YT / July 1, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) is pleased to provide an update regarding commercial production and Covid-19 protocols as production continues at the Eagle Gold Mine […]
– FDA provides very specific guidelines to study iPSC-derived MSCs – Company intends to submit an IND application for its iMSC therapy for patients with ARDS associated with COVID-19 CRANFORD, N.J., June 26, 2020 /PRNewswire/ […]
PRINCETON, N.J., June 24, 2020 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced […]
Company Proactively Reduces Debt by Converting 18.5% of the Principal Amount of its Senior Note due April 2021 into Equity with Limited Dilution and Zero Warrants CYPRESS, CA / ACCESSWIRE / June 10, 2020 / KushCo […]
Salt Lake City, Utah – June 9, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it is expected to join the […]
Tissue from presymptomatic patient in Italy was found to contain SARS-CoV-2 using Company’s Logix Smart™ COVID-19 test kit Salt Lake City, Utah – May 26, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a […]
-The COVID-19 pandemic has highlighted the need to provide Mino-Lok on a compassionate case basis -Many patients in hospitals receive medication, chemotherapy and nutrition via central venous catheters that can become infected and may require […]
CRANFORD, N.J., May 18, 2020 /PRNewswire/ — Citius Pharmaceuticals Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously announced registered direct offering priced at-the-market under […]
Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter Salt Lake City, Utah – May 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com